Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 |
filingDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104302296-B |
titleOfInvention |
Sugar composite for treating hemophilia A and/or Feng's von Willebrand's disease |
abstract |
The present invention relates to the compositions of the sugar comprising the separation for treating Feng's von Willebrand's disease and/or hemophilia A, wherein the sugar is derived from the accessible saccharide residue of ABO (H) blood group antigens. |
priorityDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |